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Purpose: Although many studies have well established that carotid endarterectomy (CEA) is beneficial in selected patients
with severe carotid disease, only a few large studies have focused on the durability of the surgical procedure. Carotid
artery angioplasty and stenting (CAS) has recently been proposed as a potential alternative to CEA. We analyzed the
incidence of late occlusion and recurrent stenosis after CEA.
Methods: Over 13 years 1000 patients underwent 1150 CEA procedures to treat symptomatic and asymptomatic
high-grade carotid stenosis. CEA procedures involving either traditional CEA with patching (n  302) or eversion CEA
(n  848) were all performed by the same surgeon, with patients under deep general anesthesia and cerebral protection
involving continuous electroencephalographic monitoring for selective shunting. All patients underwent postoperative
duplex ultrasound scanning and clinical follow-up at 1, 6, and 12 months, and yearly thereafter. New neurologic events,
late occlusions, and recurrent stenoses 50% or greater were recorded. Complete follow-up (mean, 6.2 years; range, 6-156
months) was obtained in 95% of patients (949 of 1000), for an overall average of 95% of procedures (1092 of 1150).
Survival analysis was performed with the Kaplan-Meier life table method.
Results. Perioperative (30-day) mortality rate was 0.3% (3 of 1000), and stroke rate was 0.9% (11 of 1150), with a
combined mortality and stroke rate of 1.2%. The incidence of late occlusion and recurrent stenosis 70% or greater was
0.6% and 0.5%, respectively, with a combined occlusion and restenosis rate of 1.1%. Kaplan-Meier analysis showed that
the rate of freedom from occlusion, restenosis 70% or greater, and combined occlusion and restenosis 70% or greater at
12 years was 99,4%, 99.5%, and 98.8%, respectively. Occlusion and restenosis developed asymptomatically.
Conclusions: CEA is a low-risk procedure for treating severe symptomatic and asymptomatic carotid disease, with excellent
long-term durability. Proponents of CAS should bear this in mind before considering CAS as a routine alternative to
CEA. (J Vasc Surg 2004;40:270-8.)To date carotid endarterectomy (CEA) is the only
revascularization procedure with proved efficacy in reduc-
ing the risk for stroke in patients with symptomatic and
asymptomatic high-grade extracranial internal carotid ar-
tery (ICA) stenosis.1-3 Although perioperative stroke rates
of 6% in patients with symptomatic disease and 3% in
patients with asymptomatic disease are still considered ac-
ceptable,4 CEA is now being performed at many single-
institution centers with much lower risk, and a periopera-
tive stroke rate of 2% or less in symptomatic disease and less
than 1% in asymptomatic disease can be expected as a
rule.5-15 Moreover, the reported incidence of recurrent
ICA stenosis after primary CEA varies considerably be-
tween centers,16-22 but the overall risk for recurrent steno-
sis seems low; only 1% to 8% are symptomatic and require a
repeat operation.20-22
Carotid angioplasty and stenting (CAS) has recently
emerged as a useful and potentially less invasive alternative
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doi:10.1016/j.jvs.2004.04.005270to CEA.23-29 Despite the still limited prospective con-
trolled data comparing the relative risks and benefits of CAS
with respect to CEA,30,31 extensive worldwide experience
has been collected outside of randomized trials to support
the conviction that CAS can be performed successfully in
selected patients once sufficient technical expertise has been
acquired. However, despite several thousand CAS proce-
dures having been reported to date, there is still grave
concern as to the long-term durability of CAS.
Inasmuch as there are few long-term studies in the
literature that evaluated the durability of CEA in a suffi-
ciently large number of patients, and because the results of
such studies would be essential to enable comparison of the
durability of CAS, the purpose of the present analysis was to
determine the occlusion and restenosis rates after CEA
performed at a single institution in a relatively large sample
with a relatively long follow-up.
METHODS
Over 13 years, 1150 consecutive CEA procedures were
performed by the same surgeon (E.B.) in 1000 patients,
and entered prospectively into a computerized registry.
Many of these CEA procedures joined 2 different prospec-
tive randomized trials that evaluated the early and late
outcome of traditional CEA with routine patch angioplasty
versus eversion CEA.32,33 One hundred fifty patients un-
derwent bilateral CEA: bilateral eversion CEA in 44 pa-
tients; bilateral CEA with patching in 10 patients; and
bilateral mixed CEA, that is, eversion CEA on one side and
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Bilateral CEA was planned at admission in 109 patients
(72.6%), with a mean of 7  2 weeks between procedures,
and in 41 patients (27.4%) indications for contralateral
CEA developed at a mean of 23  7 months after the first
procedure. Data for patients scheduled for CEA with con-
comitant coronary artery bypass grafting and for patients
with associated supra-aortic trunk lesions requiring concur-
rent surgery were excluded from the analysis.
Patient demographic data were collected, including any
history of diabetes mellitus, cigarette smoking, hyperten-
sion and coronary artery disease, other clinical variables,
indications for surgery, details of the operation, and hospi-
tal length of stay.
The ICA lesion was diagnosed at preoperative tradi-
tional angiography during the earlier part of this experience
(used with decreasing frequency over the years), whereas
duplex ultrasound (US) scanning was the only preoperative
ICA imaging study performed in most patients from mid-
1998 and after, combined in selected patients with either
magnetic resonance angiography, computed tomography
(CT) angiography, or traditional arteriography. The radi-
ologist’s estimate of any carotid bulb or ICA stenosis from
the final angiography report was recorded with the North
American Symptomatic Carotid Endarterectomy Trial
(NASCET) method.1 If no arteriography was performed,
stenosis was estimated on the basis of findings at preoper-
ative duplex US scanning, performed in our vascular labo-
ratory. The velocity criteria used to categorize the degree of
stenosis revealed a satisfactory correlation with the angio-
graphic findings when the degree of stenosis was calculated
as the percentage of diameter reduction in compliance with
the NASCET method.1 These criteria have been pub-
lished.34,35
Clinical findings at presentation were always classified
by the consultant neurologist as transient ischemic attack
(temporary hemispheric symptoms lasting no more than 24
hours, with complete recovery), amaurosis fugax (transient
monocular visual loss), or stroke (neurologic deficit persist-
ing for more than 24 hours, regardless of the mechanism
and related to either cerebral hemisphere). Patients with
nonhemispheric symptoms, such as episodes of dizziness or
vertigo, were included in the asymptomatic group.
Preoperative cerebral CT was performed in all patients
with symptomatic disease. Preoperative and postoperative
cranial nerve assessment was performed in all patients by a
neurologist and an otolaryngologist. Vocal cord move-
ments were assessed with direct fiberoptic laryngoscopy in
patients with symptoms or signs of vagus nerve injury.36
Preoperative patient preparation was standardized. To re-
duce the incidence of neck hematomas, antiplatelet therapy
(aspirin or dipyridamole, and ticlopidine or clopidogrel in
the final period) was suspended at least 1 week before
surgery, and was not resumed until the patient was dis-
charged from the hospital.
All CEA procedures involved either traditional CEA
with patching (n  302) or eversion CEA (n  848). The
technical details of both procedures have been de-scribed.32,37 Polytetrafluoroethylene (Gore-Tex; W. L.
Gore) was the patch material used in all 302 CEAs with
patching. In the first period of the study all patients under-
went CEA with routine patching, and in 1992 we started to
perform eversion CEA. Over time, and as we gained expe-
rience with the technique, almost all patients underwent
eversion CEA. From 1998 onward we performed only
eversion CEA to treat primary carotid occlusive disease.
All CEA procedures were performed with patients un-
der deep general anesthesia and cerebral protection involv-
ing continuous perioperative electroencephalographic
(EEG) monitoring for selective shunting. All perioperative
EEGs were visually analyzed by a neurologist with extensive
experience in interpretation of studies during sleep, either
natural or induced with hypnotic or anesthetic agents.
Shunting criteria were based exclusively on EEG changes
consistent with cerebral ischemia. Completion imaging
studies were not performed.
Patients were usually monitored in the recovery room
for 2 hours, until blood pressure and neurologic status were
considered acceptable, before being transferred to a regular
nursing unit that specializes in vascular care, and were
monitored for 12 to 24 hours after surgery. All patients
with severe headache were observed for hyperperfusion
syndrome, and hypertension was treated aggressively. Most
patients were discharged 48 to 72 hours after CEA.
Surveillance protocol. After discharge, visiting nurses
monitored the patients’ blood pressure and neurologic
status. Clinical evaluation and duplex US scans were per-
formed systematically by a consultant neurologist and 2
experienced technologists in all surviving patients, at 1, 6,
and 12 months, and once every year thereafter, to assess any
residual ICA stenosis, angulation, recurrent ICA disease, or
occlusion, with an Acuson Sequoia 512 ultrasound system.
A 5.0-MHz linear scan transducer was used with a 5-mm
axial extension of the sample volume and a consistent
60-degree angle of insonation. Residual stenosis was re-
corded as present when lumen reduction 30% or greater
was noted at the proximal or distal end of the endarterec-
tomized site at 30-day follow-up. Residual angulation was
defined as a kink greater than 60 degrees detected just
beyond the distal end of the patch or endarterectomized
zone on the 30-day duplex US scan. Recurrent ICA disease
was diagnosed only if the abnormality became apparent
subsequent to a normal duplex US scan or more than 12
months after the initial examination. Peak systolic velocity
greater than 140 cm/s, with spectral broadening through-
out systole, and increased diastolic velocity were consistent
with stenosis 50% or greater, and peak systolic velocity
greater than 210 cm/s with end-diastolic velocity 110 to
140 cm/s was consistent with stenosis 70% or greater.
Stenosis 70% or greater identified at duplex US scanning
was confirmed with either carotid CT angiography or tra-
ditional arteriography. The study end points were periop-
erative stroke and death, restenosis 70% or greater, and late
occlusion.
All patients were evaluated postoperatively by a consul-
tant neurologist. Minor stroke was defined as minimal and
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for more than 24 hours but not leading to disability or
significant impairment in activities of daily living. Major
stroke was defined as a deficit lasting more than 30 days and
inducing a change in lifestyle. Cerebral CT or magnetic
resonance was performed in all patients with a new neuro-
logic deficit after CEA. Other perioperative complications
and events observed during follow-up were recorded in
accordance with the guidelines of the Ad Hoc Committee
on Reporting Standards for Cerebrovascular Disease, Soci-
ety for Vascular Surgery/North American Chapter of the
International Society for Cardiovascular Surgery.38
Statistical analysis. All values are expressed as mean
SD. Cumulative life table analyses (Kaplan-Meier method)
were performed to assess the incidence of occlusion and
restenosis 50% or greater over time, and stroke-free and late
survival rates. Statistical significance was inferred at P .05.
Cox proportional hazards multivariate analysis was used to
determine which factors could influence long-term out-
come. Inasmuch as each perioperative and late outcome
was correlated with the surgical procedure, and because
patients who underwent bilateral CEA were exposed to
twice the risk for stroke or carotid occlusion or restenosis,
several data items were analyzed vis-a`-vis surgical proce-
dures rather than patients.
RESULTS
Clinical features and several perioperative findings are
shown in Table I for all patients. Of the 1000 patients who
underwent CEA, 679 were men (772 CEA procedures)
and 321 were women (378 CEA procedures), with mean
Table I. Baseline characteristics
n %
Parients 1000
Procedures 1150
Age (y)
Mean  SD 72  6.18
Range 31-93
Male gender 679 67.9
Risk factors
Hypertension 607 60.7
Hyperlipidemia 439 43.9
Current smoking or history of smoking 717 71.7
Diabetes 323 32.3
Coronary artery disease 445 44.5
Peripheral vascular disease/AAA 529 52.9
Symptomatic disease 771 67.0
Transient ischemic attack 476 61.8
Amaurosis fugax 156 20.2
Stroke 139 18.0
Asymptomatic disease 379 33.0
Contralateral carotid occlusion 135 13.5
CEA with patching 302 26.2
Eversion CEA 848 73.8
Perioperative EEG changes 243 21.1
Shunting 163 14.2
AAA, Abdominal aortic aneurysm; CEA, carotid endarterectomy; EEG,
electroencephalogram.age 72  6 years. Of note, 135 patients had contralateral
ICA occlusion, 475 had coronary artery disease, and 323
had diabetes. CEA procedures were performed to treat
symptomatic severe ICA lesions in 771 patients (67%)
Eversion CEA was performed in more than 70% of proce-
dures.
Perioperative death and stroke rates. The 30-day
mortality rate was 0.3% (3 of 1000), and the stroke rate was
0.9% (11 of 1150), with a combined mortality and stroke
rate of 1.2%. There were 3 perioperative deaths: 2 due to
myocardial infarction, and 1 due to stroke. The only fatal
perioperative stroke occurred in a patient with symptomatic
disease undergoing CEA with patching to treat a severe
ulcerated left ICA lesion. EEG monitoring had been un-
eventful throughout the operation, and shunting was un-
necessary. The patient awoke from anesthesia with no
neurologic symptoms, but subsequently experienced pro-
gressive right-sided hemiparesis, and died on postoperative
day 10 of recurrent progressive stroke. None of the other
10 patients with perioperative stroke (6 CEA procedures
with patching, 4 eversion CEAs) was shunted, because
EEG monitoring was uneventful throughout the opera-
tion. All awoke from anesthesia with no apparent neuro-
logic deficit or stroke. In all cases stroke occurred within the
first 24 hours after surgery, while the patient was in the
recovery room. Duplex US scans immediately confirmed
ICA occlusion in the patients who had undergone CEA
with patching, and demonstrated ICA patency in patients
who had undergone eversion CEA. In the CEA with patch-
ing group, 4 patients underwent repeat operation consist-
ing of thrombectomy and new patch plasty, with some
improvement in neurologic status in only 1 patient and no
improvement in the others. The remaining 2 strokes in-
volved the hemisphere contralateral to the side operated
on. One of these was ipsilateral to an occluded ICA. Among
the 4 strokes in the eversion CEA group, 2 were major and
2 were minor. Both major strokes occurred in patients (1
with a shunt) with a mildly diseased contralateral ICA, and
were probably embolic from the aortic arch or from the
heart, because cerebral CT scans demonstrated a cortical
infarction in the territory of the middle cerebral artery.
Both minor strokes were most likely hemodynamic, as
suggested by findings on the CT images. One developed in
the hemisphere contralateral to the revascularized ICA and
ipsilateral to an occluded ICA.
No hyperperfusion syndrome was observed in any pa-
tient. Overall, 31 angulations and 21 residual stenoses were
detected on the 30-day duplex US scans of the operated
vessels (Table II).
Other important surgical morbidity included an overall
5% incidence of nerve injury (58 of 1150). Injuries involved
the cranial nerves in 4.5% of cases (48 of 1150) and the
cervical nerves in 0.5% (10 of 1150). There were 25 hypo-
glossal nerve injuries, 12 recurrent laryngeal nerve injuries,
7 superior laryngeal nerve injuries, 4 marginal mandibular
nerve injuries, 7 greater auricular nerve injuries, and 3
transverse cervical nerve injuries. All nerve dysfunctions
were transient, and all but 4 recurrent laryngeal nerves
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tients regained full function within 12 months, whereas the
other 2 did not recover until 31 and 37 months, respec-
tively.
Long-term results. Complete follow-up (mean, 6.2
years; range, 6-156 months) was obtained in 95% of pa-
tients (949 of 1000), for an overall of 95% of CEA proce-
dures (1092 of 1150). After excluding the 3 perioperative
deaths, 997 patients were alive 30 days after CEA, but 48
were lost to follow-up.
Overall, there were 7 ICA occlusions (0.6%), in 6
patched arteries and 1 everted artery (Table II). All occlu-
sions involved ICAs that were not shunted, and occurred
without symptoms within the first postoperative year, all in
arteries apparently patent on the first 2 duplex US scans but
demonstrating residual angulation on the 30-day duplex
US scan. Freedom from all occlusions at 1, 3, 5, 7, 10, and
12 years was 99.4%, 99.4%, 99.4%, 99.4%, 99.4%, and
99.4%, respectively (Fig 1).
Overall, there were 12 recurrent stenoses (1.1%) 50% or
greater, 11 of which were detected in patched arteries. Of
the 12 restenoses, 6 (0.5%) were 70% or greater, for a
combined occlusion and restenoses 70% or greater rate of
1.1% (Table II). All recurrent stenoses involved ICAs that
were not shunted, and occurred without symptoms after
the first postoperative year. All but 1 of the restenoses
remained stable on subsequent duplex US scans, and all but
1 were treated conservatively. In 1 patched artery restenosis
70% or greater progressed rapidly and became severe
enough (90%) to necessitate a second operation 19
months after the first operation. Kaplan-Meier analysis
showed that freedom from all restenoses 50% or greater at
1, 3, 5, 7, 10, and 12 years was 100%, 99.4%, 98.9%, 98.9%,
98.9%, and 98.9%, respectively (Fig 2). When the outcomes
were stratified into patched versus everted arteries the free-
dom from restenoses 50% or greater at 1, 3, 5, 7, 10, and 12
years was 100%, 97.8%, 95.8%, 95.8%, 95.8%, and 95.8%
versus 100%, 99.9%, 99.9%, 99.9%, 99.9%, and 99.9%,
Table II. Early (30-day) and late results
To
n
Early results (30 d) N 
Stroke 11
Death 3
Nerve injury 58
Residual angulation 31
Residual stenosis 21
Late results (mean, 6.2 y; range, 6-156 mo) n 
All restenoses  50% 12
Restenoses  70% 6
Occlusions 7
Restenoses  70%  occlusions 13
Stroke 4
Death 84respectively. Freedom from restenoses 70% or greater at 1,
3, 5, 7, 10, and 12 years was 100%, 99.5%, 99.5%, 99.5%,
99.5%, and 99.5%, respectively (Fig 2). When the outcomes
were stratified into patched versus everted arteries the free-
dom from restenoses 70% or greater at 1, 3, 5, 7, 10, and 12
years was 100%, 98.2%, 98.2%, 98.2%, 98.2%, and 98.2%
versus 100%, 99.9%, 99.9%, 99.9%, 99.9%, and 99.9%,
respectively. Freedom from combined occlusion and reste-
nosis 70% or greater at 1, 3, 5, 7, 10, and 12 years was
99.4%, 98.8%, 98.8%, 98.8%, 98.8%, and 98.8%, respec-
tively (Fig 1). When the outcomes were stratified into
patched versus everted arteries, freedom from combined
occlusion and restenosis 70% or greater at 1, 3, 5, 7, 10, and
12 years was 97.9%, 96.1%, 96.1%, 96.1%, 96.1%, and
96.1% versus 99.9%, 99.8%, 99.8%, 99.8%, 99.8%, and
99.8%, respectively.
Overall, there were 4 late strokes. One was cardioem-
bolic (fatal stroke in a patient with atrial fibrillation of
recent onset), and 3 were lacunar. Kaplan-Meier analysis
showed that freedom from all strokes at 1, 3, 5, 7, 10, and
12 years was 100%, 99.8%, 99.6%, 99.6%, 99.6%, and
99.6%, respectively (Fig 3).
Eighty-four late deaths occurred in the series as a
whole. The cause of late death was primarily cardiac related
(n  38; Table III). Freedom from death at 1, 3, 5, 7, 10,
and 12 years was 99.9%, 96.1%, 92.8%, 91.3%, 87.2%, and
79.3%, respectively (Fig 4).
At multivariate analysis the occurrence of late occlusion
was significantly associated with patch closure (P  .04)
and the presence of angulation at the 30-day control duplex
US scan (P .0001), whereas severe recurrent stenosis was
associated more strongly with patch closure (P  .002).
Age, gender, symptomatic disease, diabetes mellitus, ca-
rotid artery diameter at surgery, coronary artery disease,
serum triglyceride or cholesterol concentrations, and hy-
pertension were not significantly associated with the occur-
rence of late occlusion or recurrent stenosis.
CEA with
patching Eversion CEA
% n % n %
n  302 n  848
0.9 7 0.6 4 0.3
0.3 3 1.2 0
5 12 3.9 46 5.4
2.7 31 2.7 0
1.8 15 1.3 6 0.5
n  264 n  825
1.1 11 4.1 1 0.1
0.5 5 1.9 1 0.1
0.6 6 2.2 1 0.1
1.1 11 4.1 2 0.2
0.3 3 1.1 1 0.1
8.8 31 15 53 7.1tal
1150
1089
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70%(open circle). Numbers at bottom of graphic correspond to number of patients at risk at the beginning of each
time interval. Vertical bars at each time point represent standard error for the interval.Fig 2. Kaplan-Meier curves show freedom from all recurrent stenoses (open circle) and restenosis 70% or greater (solid
circle). Numbers at bottom of graphic correspond to number of patients at risk at the beginning of each time interval.
Vertical bars at each time point represent standard error for the interval.
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The benefit of CEA for stroke prevention in selected
patients with symptomatic and asymptomatic disease with
severe carotid lesions has recently been established in con-
trolled randomized clinical trials,1-3 with acceptably low
perioperative stroke and death rates.4 The incidence of
CEA-related stroke and death must be 6% or less in patients
with symptoms and less than 3% in patients without symp-
toms for the benefit to hold true over 5 years. Many
single-institution reports anecdotally claim a much lower
incidence of stroke and death in patients with symptomatic
and asymptomatic severe carotid lesions, however.
The results of the present study of 1150 CEA proce-
dures (perioperative mortality rate, 0.3%; stroke rate, 0.9%;
Fig 3. Kaplan-Meier curve of risk of late strokes. The nu
of patients at risk at the beginning of each time interval. T
for the interval.
Table III. Causes of late death
Cause n %
Myocardial infarction 38 45.2
Rupture of abdominal aortic
aneurysm
1 1.2
Stroke 1 1.2
Pancreatitis 4 4.7
Cancer 18 21.4
Renal failure 7 8.3
Suicide 1 1.2
Car accident 5 6
Trauma 3 3.6
Unknown 6 7.1combined perioperative mortality and stroke rate, 1.2%)
correlate well with recently published large series (500
CEA procedures) that report 30-day major stroke and
death rates ranging from 0.9% to 4%5,13 and recurrent
stenosis rates of 0.7% to 13.6%5,8 over an average of 3.3
years (Table IV).
Inasmuch as the incidence of late occlusion and reste-
nosis after CEA can be interpreted as a measure of the
durability of CEA, our combined occlusion and restenosis
rate of 1.1% over an average of 6.2 years (the second longest
follow-up to date of CEA used to treat ICA lesions, after
the report from Ecker et al15 of 975 patients and 1000
CEAs, with average follow-up of 7.1 years) demonstrates
that CEA is a durable procedure.
It is surprising that no occlusions resulted from pro-
gression of restenosis. All occlusions developed in patched
ICAs with residual angulation on 30-day duplex US scans,
and at multivariate analysis it was concluded that residual
angulation and patch closure are significantly associated
with late occlusion (P  .0001 and P  .04, respectively).
The reason that residual angulation disappears in the first
few years after surgery (no residual angulation was detected
on late duplex US scans) in most cases, while progressing
asymptomatically toward occlusion in a few others, is hard
to say, and might warrant further speculation. However,
inasmuch as we observed angulation in all patched arteries
that primarily thrombosed and required exploration (the
ICA was occluded and acutely angulated at the end of the
distal angle of the patch closure), we might suppose that the
s at the bottom of the graphic correspond to the number
rtical bars at each time point represent the standard errormber
he ve
ch ti
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insignificant elongation remains, sometimes increased by
the natural weakness of the endarterectomized arterial wall,
modest angulation might occur just beyond the distal end
of the patch. When the clamps are removed and blood flow
is restored, the systolic thrust may drive the stiff patched
segment forward against the weakened and angulated
patch-free segment beyond, thus accounting for delayed
thrombosis in a few cases. Similar dynamics could also
account for late occlusion in these vessels. The one occlu-
sion in an everted vessel is also difficult to explain, inasmuch
as the ICA seemed normal on previous duplex US scans.
Recurrent carotid stenosis after CEA remains a thera-
peutic conundrum. Reports of its incidence vary widely,
and review of the literature is challenging because of differ-
ences in the duration of follow-up, criteria used to deter-
mine and define recurrent stenosis, and methods used to
close the arteriotomy. The time it takes for recurrent lesions
to develop also varies considerably, depending on the dif-
ferent pathologic features of the lesions and their related
morbidity. Early restenosis (within 24 months) is usually a
consequence of myointimal hyperplasia, whereas stenosis
occurring later is generally associated with atherosclerosis.
In this series all restenoses 70% or greater occurred within
24 months after surgery, and all but 1 remained stable at
subsequent control duplex US scans. Although the purpose
of this study was not to compare the results of 2 techniques
of closure of the arteriotomy, the rates of occlusion, total
restenosis, restenosis 70% or greater, and combined occlu-
sion and restenosis 70% or greater were higher after patch-
Fig 4. Kaplan-Meier curve of late survival rates. Number
at the beginning of each time interval. Vertical bars at eaing CEA than after eversion CEA (2.2% vs 0.1%, 4.1% vs
0.1%, 1.8% vs 0.1%, 4.1% vs 0.2%, respectively). Moreover,
multivariate analysis demonstrated that patch closure is
significantly associated with severe recurrent stenosis (P 
.002). These data are consistent with those of other inves-
tigators, who found restenosis rates clearly lower after
eversion CEA (range, 0.2%-2.8%) than after patch CEA
(range, 0.7%-5.8%) or primary closure (range, 1%-11%;
Table IV).
Any extensive review of early and late results in patients
who undergo CAS is bound to be methodologically flawed,
because the procedure is constantly evolving from a tech-
nical standpoint, new stents are rapidly being developed,
and a variety of distal protection devices are being intro-
duced. However, in a recent meta-analysis of 2537 CAS
procedures performed without cerebral protection and 896
CAS procedures performed with cerebral protection, Kas-
trup et al39 found a significantly higher combined 30-day
stroke and death rate in patients without cerebral protec-
tion (5.5%; 140 of 2537) compared with those with cere-
bral protection (1.8%; 16 of 896; P  .001). This was
mainly due to fewer minor and major strokes in patients
with cerebral protection (0.5% vs 3.7% [P .001] and 0.3%
vs 1.1% [P .05], respectively), whereas the death rate was
much the same (0.8%).
There is still reason for concern about the long-term
durability of the CAS procedure. Data regarding restenosis
are only available in a few studies, most of which had a
relatively short follow-up. Moreover, recurrence was re-
ported with weighting each procedure equally, regardless
ttom of graphic correspond to number of patients at risk
me point represent standard error for the interval.s at bo
; NR,
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rate of 3.5% in 135 CAS procedures with a mean follow-up
of 16 months; Becquemin et al40 reported a restenosis rate
of 7.5% in 107 CAS procedures with a mean follow-up of
15 months; and more recently McKevitt et al41 reported a
restenosis rate of 15.5% after 333 CAS procedures with a
mean follow-up of 12 months. In a series of 217 CAS
procedures with a mean neurologic follow-up of 13
months, Christiaans et al42 found that restenosis after CAS
was common (21%), located mainly in the central body of
the stent, related to loss of proximal stent apposition alone,
and symptomatic in 7% of patients. With longer follow-up
and using life table analysis, Lal et al43 demonstrated recur-
rent stenotic lesions (ranging from 40% to 99%, none
associated with neurologic events) in a significant number
of patients (22 of 122, 18%; mean follow-up, 18 months),
and the severe restenosis (80%) rate at 5 years was 6.4%;
yet only 4 of the original 122 patients could be evaluated at
60 months.
While the 30-day mortality and stroke rates for CAS in
experienced centers can be acceptable, especially since the
Table IV. Large series of carotid endarterectomies: early a
Year Author
Study
type
Mean
follow-up
(mo)
No. of
CEA
Symptoma
(%)
1987 Hertzer et al5 PS 21 917 49
1990 Rosenthal et al6 RS 38 1000 82
1996 Plestis et al7 RS 61 1006 67
1997 Lawhorne et al8 RS 24 500 71
1998 Shah et al9 RS 18 2723 36
2000 Radak et al10 PS 56 2806 96
2000 Cao et al11 PR 33 1353 59
2000 Archie12 RS 55 1360 62
2001 Scavee et al13 RS 49 600 46
2002 Trisal et al14 RS NR 1648 NR
2003 Ecker et al15 PS 82 1000 59
2004 Present series RS 74 1150 67
PR, Prospective randomized; PS, prospective series; RS, retrospective seriesintroduction of cerebral protection devices, available fol-
low-up data suggest that the durability of CAS remains
uncertain.
In conclusion, the results of the present study demon-
strate that CEA is a safe, effective, and durable procedure
and that it can be performed with excellent results in
patients with symptomatic and asymptomatic severe ICA
lesions. Although use of cerebral protection devices has
reduced the thromboembolic complications (minor and
major stroke) with CAS, making the periprocedural risk
rates after CAS resulting from single-institution and indus-
try-sponsored trials comparable with perioperative risk
rates after CEA emerging from many excellent large, insti-
tutional series, the durability of the less invasive procedure
may be poor.
To validate the effectiveness of CAS as an alternative to
CEA, properly performed randomized trials will have to
take into account the rapid improvements in the field of
endovascular technology, and adequate follow-up of sev-
eral years to assess the incidence of recurrent stenosis and
the long-term functional outcome of the procedure.
te results
Death/stroke
(% at 30 days)
Percent
restenosis
criterion Method of closure
Occlusion plus
restenosis (%)
4 50 Patch 47% 2.6
Eversion 0% —
Primary 53% 11
2.3 50 Patch 75% 3.1
Eversion 0% —
Primary 25% 4.0
2 75 Patch 100% 4.1
Eversion 0% —
Primary 0% —
1 80 Patch 86% 0.7
Eversion 0% —
Primary 14% —
2.3 NR Patch 3% —
Eversion 82% 0.3
Primary 15% 1
2.1 50 Patch 24% 3.1
Eversion 76% 1.1
Primary 0% —
2.6 50 Patch 19% 1.5
Eversion 50% 2.8
Primary 31% 7.9
2.1 50 Patch 99.6% 2.1
Eversion 0% —
Primary 0.4% —
0.9 50 Patch 100% 5.8
Eversion 0% —
Primary 0% —
NR 70 Patch 62% 3.8
Eversion 0% —
Primary 38% 5.8
1.9 70 Patch 100% 1.0
Eversion 0% —
Primary 0% —
1.2 70 Patch 26% 4.1
Eversion 74% 0.2
Primary 0% —
not reported.nd la
tic
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